Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors.
The agreement involves purchasing 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are about $3.9 million before deductions.
Securities Purchase Agreement
Entered into an agreement to purchase 3,225,000 shares of common stock.
Offering Price
Shares offered at a price of $1.20 per share.
Gross Proceeds
Expected gross proceeds from the offering are approximately $3.9 million.
- The offering is expected to provide additional funds for the Company's operations.
- The agreement with institutional investors highlights investor confidence in Scienture Holdings.
The securities purchase agreement marks a significant milestone for Scienture Holdings, reinforcing its commitment to enhancing value for patients and caregivers through specialty pharmaceutical products.